Skip to main content
See every side of every news story
Published loading...Updated

Corbus Pharmaceuticals Announces Pricing of Public Offering - Corbus Pharmaceuticals (NASDAQ:CRBP)

Summary by Benzinga
NORWOOD, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) ("Corbus" or the "Company"), an oncology and obesity company, today announced the pricing of an underwritten public offering of 4,744,231 shares of its common stock at a public offering price of $13.00 per share, and, in lieu of common stock to certain investors, pre-funded warrants to purchase 1,025,000 shares of its common stock, at a public o…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Friday, October 31, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal